Titel: Ethics and the Business of Biomedicine

Termin: 6.4.2006 bis 8.4.2006

Veranstaltungsort:
University of Tennessee
Knoxville

Referenten: Tom Beauchamp (Georgetown University) *** Daniel Callahan (Harvard University and The Hastings Center) *** Norman Daniels (Harvard University) *** Richard T. De George (University of Kansas) *** Carl Elliott (University of Minnesota) *** George Khushf (University of South Carolina) *** Paul T. Menzel (Pacific Lutheran University) *** Mary V. Rorty (Stanford University) *** Daniel Wikler (Harvard University) *** Laurie Zoloth (Northwestern University) *** Norman E. Bowie (University of Minnesota , Twin Cities) *** George Brenkert (Georgetown University) *** E. Haavi Morreim (University of Tennessee , Memphis) *** Patricia Werhane (DePaul University and University of Virginia)

Weitere Informationen:
http://web.utk.edu/~philosop/biomedconf.html

Kurzbeschreibung: Central to current national discourse are concerns about ethics, costs, and profits in relation to health care. These concerns are driven by major shifts in health care that took place during the 20th century. These shifts include the transformation of the professional practice of medicine from a service orientation to a market orientation; the emergence of powerful pharmaceutical and health care corporations; and development and new, innovative, and expensive biomedical technologies by for profit enterprises. While there are interesting public policy dimensions to this discourse, sound public policy decisions must be informed by careful attention to foundational questions about the specific values (e.g., distribute justice, rights, human dignity, and community welfare) that inform, or should inform organizational decisions and public policy judgments. This conference will focus on foundational questions concerning values in relation to the business of medicine. Conference papers will focus on such topics as:

* Ethical issues concerning the pharmaceutical industry such as marketing; pricing; and research and development of life-savings drugs most needed by people in the developing world.

* Ethical issues concerning the purposes and function of HMOs, insurance companies, and physician practice groups, such as pricing, capatation, resource scarcity, and appropriate standards of care.

Kontakt: Prof. Denis G. Arnold, Ph.D.
Department of Philosophy
College of Arts and Sciences
University of Tennessee
801 McClung Tower
Knoxville, Tennessee 37996-0480
United States
Tel.: +1 - 865 - 9 74 72 19
Fax: +1 - 865 - 9 74 35 09
darnold1@utk.edu
http://web.utk.edu/~philosop/

Veranstalter: Department of Philosophy at University of Tennessee

Schlagworte: Gesundheitswesen, Medizinische Ethik, Pharmazeutik